A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia

Conclusions: This multicenter, placebo-controlled, randomized withdrawal study demonstrated the efficacy of lurasidone for the maintenance treatment of patients with schizophrenia.

http://jop.sagepub.com/cgi/content/abstract/30/1/69?rss=1

Source: Journal of Psychopharmacology - December 23, 2015 Category: Psychiatry Authors: Tandon, R., Cucchiaro, J., Phillips, D., Hernandez, D., Mao, Y., Pikalov, A., Loebel, A. Tags: Original Papers Source Type: research

More News: Psychiatry | Schizophrenia | Study